Kayla Rabideau
Psychiatric/Mental Health · Plattsburgh, NYNPI 1548823180
Payments from drug & device makers
Across 102 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$354
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$290
- Teva Pharmaceuticals USA, Inc.$260
- Otsuka America Pharmaceutical, Inc.$202
- Indivior Inc.$143
- Fisher & Paykel Healthcare Inc$106
- plus $634 from 12 others
What the payments were for
- Food & beverage$1,990100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $354 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $290 |
| Teva Pharmaceuticals USA, Inc. | 12 | $260 |
| Otsuka America Pharmaceutical, Inc. | 10 | $202 |
| Indivior Inc. | 8 | $143 |
| Fisher & Paykel Healthcare Inc | 4 | $106 |
| Neurocrine Biosciences, Inc. | 5 | $106 |
| Johnson & Johnson | 4 | $104 |
| Alkermes, Inc. | 5 | $103 |
| Lundbeck LLC | 4 | $88 |
| Corium, LLC | 6 | $59 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Almatica Pharma LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Bausch Health US, LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Biogen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$103
How this compares
$1,990 in reported general payments places this provider in the 75th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 12 | $74,094 |
| Bupropion XlBupropion Hcl | 31 | $454 |
| Duloxetine Hcl | 27 | $387 |
| Clonazepam | 24 | $376 |
| Quetiapine Fumarate | 15 | $361 |
| Gabapentin | 13 | $324 |
| Lamotrigine | 26 | $314 |
| Alprazolam | 22 | $279 |
| Buspirone Hcl | 12 | $221 |
| Trazodone Hcl | 33 | $172 |
| Pantoprazole Sodium | 12 | $52 |
| Fluoxetine Hcl | 17 | $49 |
| Risperidone | 13 | $49 |
| Escitalopram Oxalate | 14 | $46 |
| Lorazepam | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $260 | $74,09412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Plattsburgh
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Mary OlsonNew York$142K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.